NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE212133 Query DataSets for GSE212133
Status Public on Jan 03, 2024
Title Establishing mRNA and miRNA interactions driving disease heterogeneity in ALS patient survival (miRNA-Seq)
Organism Homo sapiens
Experiment type Non-coding RNA profiling by high throughput sequencing
Summary Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, associated with the degeneration of both upper and lower motor neurons of the motor cortex, brainstem and spinal cord. Death in most patients results from respiratory failure within 3-4 years from symptom onset. However, due to disease heterogeneity some individuals survive only months from symptom onset while others live for several years. Identifying specific biomarkers that aid in establishing disease prognosis, particularly in terms of predicting disease progression, will help our understanding of ALS pathophysiology and could be used to monitor a patient’s response to drugs and therapeutic agents. Transcriptomic profiling technologies are continually evolving, enabling us to identify key gene changes in biological processes associated with disease. MicroRNAs (miRNAs) are small non-coding RNAs typically associated with regulating gene expression, by degrading mRNA or reducing levels of gene expression. Being able to associate gene expression changes with corresponding miRNA changes would help to distinguish a more complex biomarker signature enabling us to address key challenges associated with complex diseases such as ALS. The present study aimed to investigate the transcriptomic profile (mRNA and miRNA) of lymphoblastoid cell lines (LCLs) from ALS patients to identify key signatures that are distinguishable in those patients who suffered a short disease duration (< 12 months) compared to those that had a longer disease duration (>6 years). Transcriptional profiling of miRNA-mRNA interactions from LCL’s in ALS patients revealed dysregulation of genes involved in cell cycle, DNA damage and RNA processing in patients with longer survival from disease onset compared to those with short survival. Understanding these particular miRNA-mRNA interactions and the pathways in which they are involved may help to distinguish potential therapeutic targets that could exert neuroprotective effects to prolong the life expectancy of ALS patients.
 
Overall design The present study aimed to investigate the transcriptomic profile (mRNA and miRNA) of lymphoblastoid cell lines (LCLs) from ALS patients to identify key signatures that are distinguishable in those patients who suffered a short disease duration (< 12 months) compared to those that had a longer disease duration (>6 years). Affymetrix Human Exon 1.0ST GeneChip microarrays were used to assess mRNA/gene changes, while small RNA sequencing of miRNA extracted from peripheral LCL’s from ALS patients with short and long disease was performed using the Illumina TruSeq Small RNA library preparation kit and Illumina HiScanSQ.
 
Contributor(s) Waller R, Bury JJ, Appleby-Mallinder C, Wyles M, Loxley G, Babel A, Shekari S, Kazoka M, Wolff H, Heath PR, Shaw PJ, Kirby J
Citation(s) 38162899
Submission date Aug 26, 2022
Last update date Jan 04, 2024
Contact name Rachel Waller
E-mail(s) r.waller@sheffield.ac.uk
Organization name The University of Sheffield
Department Neuroscience
Street address SITraN, 385A Glossop Road
City SHEFFIELD
State/province South Yorkshire
ZIP/Postal code S102HQ
Country United Kingdom
 
Platforms (1)
GPL15456 Illumina HiScanSQ (Homo sapiens)
Samples (78)
GSM6509860 Long -1 R1S7
GSM6509861 Long -1 R1S7-25
GSM6509862 Long-2 R1S8
This SubSeries is part of SuperSeries:
GSE212134 Establishing mRNA and microRNA interactions driving disease heterogeneity in Amyotrophic lateral sclerosis
Relations
BioProject PRJNA874080

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE212133_RAW.tar 16.0 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap